Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Jan-10 4:30 PM View:  | Morra Bruce S Director | SCOLR Pharma Inc. (SCLR) | 04-Jan-10 | Grant | 214,285 | -- | -- | 100% 0 to 214.28K | |
| 19-Mar-09 12:00 PM View: | Taglich Michael N Director | SCOLR Pharma Inc. (SCLR) | 17-Mar-09 | Market Purchase | 2,500 | $0.25 | $625.00 | < 1% 438.29K to 440.79K | 56% |
| 19-Nov-08 5:56 PM View: | Wilds Daniel O Chief Executive Officer Director | SCOLR Pharma Inc. (SCLR) | 19-Nov-08 | Market Purchase | 5,000 | $0.90 | $4,520.00 | 5% 104.0K to 109.0K | (57%) |
| 13-Nov-08 12:25 PM View: | Wilds Daniel O Chief Executive Officer Director | SCOLR Pharma Inc. (SCLR) | 12-Nov-08 | Market Purchase | 5,000 | $0.89 | $4,450.00 | 5% 99.0K to 104.0K | (56%) |
| 13-Nov-08 11:43 AM View: | Mitchel Alan M Sr. VP - Chief Legal Officer | SCOLR Pharma Inc. (SCLR) | 12-Nov-08 | Market Purchase | 3,000 | $0.89 | $2,670.00 | 10% 30.0K to 33.0K | (56%) |
| 12-Nov-08 1:00 PM View: | Jeffrey Reich Director | SCOLR Pharma Inc. (SCLR) | 11-Nov-08 | Market Purchase | 25,000 | $0.93 | $23,206.00 | 100% 0 to 25.0K | (58%) |
| 02-Jun-08 1:11 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 30-May-08 | Market Purchase | 5,000 | $1.10 | $5,485.00 | 22% 22.6K to 27.6K | (79%) |
| 30-May-08 11:43 AM View: | Wilds Daniel O Chief Executive Officer Director | SCOLR Pharma Inc. (SCLR) | 30-May-08 | Market Purchase | 2,500 | $1.04 | $2,608.00 | 3% 96.5K to 99.0K | (78%) |
| 08-May-08 1:37 PM View: | Wilds Daniel O Chief Executive Officer Director | SCOLR Pharma Inc. (SCLR) | 07-May-08 | Market Purchase | 2,500 | $1.07 | $2,664.00 | 3% 94.0K to 96.5K | (78%) |
| 13-Mar-08 7:10 PM View: | Caudill Randall L W Director | SCOLR Pharma Inc. (SCLR) | 11-Mar-08 | Sale | 39,526 | $1.00 | $39,526.00 | (79%) 50.0K to 10.47K | (19%) |
| 13-Mar-08 7:10 PM View: | Caudill Randall L W Director | SCOLR Pharma Inc. (SCLR) | 11-Mar-08 | Exercise (in-the money or at-the-money) | 50,000 | $1.00 | $50,000.00 | 100% 0 to 50.0K | 19% |
| 13-Feb-08 2:22 PM View: | Turner Stephen Chief Technology Officer | SCOLR Pharma Inc. (SCLR) | 11-Feb-08 | Grant | 9,500 | -- | -- | 56% 17.0K to 26.5K | |
| 13-Feb-08 12:47 PM View: | Wilds Daniel O Chief Executive Officer Director | SCOLR Pharma Inc. (SCLR) | 11-Feb-08 | Grant | 32,000 | -- | -- | 52% 62.0K to 94.0K | |
| 13-Feb-08 12:46 PM View: | Mitchel Alan M Sr. VP - Chief Legal Officer | SCOLR Pharma Inc. (SCLR) | 11-Feb-08 | Grant | 20,000 | -- | -- | 200% 10.0K to 30.0K | |
| 13-Feb-08 12:47 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 11-Feb-08 | Grant | 17,000 | -- | -- | 100% 0 to 17.0K | |
| 25-Jan-08 7:40 PM View: | Lucas Herbert L Jr Director | SCOLR Pharma Inc. (SCLR) | 22-Jan-08 | Option Exercise | 20,000 | $1.00 | $20,000.00 | 3% 692.4K to 712.4K | (77%) |
| 18-Dec-07 2:01 PM View: | Turner Stephen Chief Technology Officer | SCOLR Pharma Inc. (SCLR) | 17-Dec-07 | Option Exercise | 10,000 | $0.56 | $5,600.00 | 143% 7.0K to 17.0K | |
| 12-Dec-07 4:00 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 11-Dec-07 | Market Purchase | 2,000 | $1.21 | $2,420.00 | 10% 20.6K to 22.6K | (81%) |
| 10-Dec-07 1:41 PM View: | Mitchel Alan M Sr. VP - Chief Legal Officer | SCOLR Pharma Inc. (SCLR) | 10-Dec-07 | Market Purchase | 3,116 | $1.23 | $3,838.84 | 45% 6.88K to 10.0K | (81%) |
| 12-Dec-07 4:00 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 10-Dec-07 | Market Purchase | 2,000 | $1.25 | $2,500.00 | 11% 18.6K to 20.6K | (81%) |
| 07-Dec-07 1:41 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 07-Dec-07 | Market Purchase | 2,000 | $1.34 | $2,680.00 | 12% 16.6K to 18.6K | (83%) |
| 07-Dec-07 1:01 PM View: | Taglich Michael N Director | SCOLR Pharma Inc. (SCLR) | 07-Dec-07 | Market Purchase | 10,000 | $1.32 | $13,200.00 | 2% 428.29K to 438.29K | (82%) |
| 10-Dec-07 1:41 PM View: | Mitchel Alan M Sr. VP - Chief Legal Officer | SCOLR Pharma Inc. (SCLR) | 07-Dec-07 | Market Purchase | 4,384 | $1.32 | $5,769.20 | 175% 2.5K to 6.88K | (82%) |
| 06-Dec-07 1:19 PM View: | Wilds Daniel O Chief Executive Officer Director | SCOLR Pharma Inc. (SCLR) | 06-Dec-07 | Market Purchase | 10,000 | $1.34 | $13,442.00 | 19% 52.0K to 62.0K | (83%) |
| 07-Dec-07 1:41 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 06-Dec-07 | Market Purchase | 2,000 | $1.34 | $2,680.00 | 14% 14.6K to 16.6K | (83%) |
| 16-May-07 2:31 PM View: | Wilds Daniel O Director | SCOLR Pharma Inc. (SCLR) | 16-May-07 | Market Purchase | 5,000 | $2.41 | $12,052.00 | 11% 47.0K to 52.0K | (90%) |
| 21-Mar-07 1:00 PM View: | Mitchel Alan M Chief Legal Officer | SCOLR Pharma Inc. (SCLR) | 20-Mar-07 | Market Purchase | 2,500 | $2.40 | $6,000.00 | 100% 0 to 2.5K | (90%) |
| 19-Mar-07 4:44 PM View: | Lucas Herbert L Jr Director | SCOLR Pharma Inc. (SCLR) | 19-Mar-07 | Option Exercise | 20,000 | $0.32 | $6,400.00 | 3% 672.4K to 692.4K | |
| 16-Mar-07 1:39 PM View: | Turner Stephen V.P., Chief Technical Officer | SCOLR Pharma Inc. (SCLR) | 16-Mar-07 | Option Exercise | 7,000 | $0.44 | $3,070.00 | 100% 0 to 7.0K | |
| 16-Mar-07 3:28 PM View: | Levy Richard M Chief Financial Officer | SCOLR Pharma Inc. (SCLR) | 16-Mar-07 | Market Purchase | 14,600 | $2.25 | $32,791.40 | 100% 0 to 14.6K | (90%) |
| 16-Mar-07 10:00 PM View: | Wilds Daniel O Director | SCOLR Pharma Inc. (SCLR) | 16-Mar-07 | Market Purchase | 10,000 | $2.25 | $22,451.00 | 27% 37.0K to 47.0K | (90%) |
| 16-Mar-07 2:30 PM View: | Taglich Michael N Director | SCOLR Pharma Inc. (SCLR) | 16-Mar-07 | Market Purchase | 30,000 | $2.32 | $69,600.00 | 8% 398.29K to 428.29K | (90%) |
| 06-Feb-07 11:53 AM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 02-Feb-07 | Option Exercise | 50,000 | $1.05 | $52,500.00 | 74627% 67 to 50.07K | |
| 14-Nov-06 5:20 PM View: | Taglich Michael N Director | SCOLR Pharma Inc. (SCLR) | 14-Nov-06 | Market Purchase | 5,000 | $4.90 | $24,500.00 | 1% 393.29K to 398.29K | (95%) |
| 13-Nov-06 12:06 PM View: | Wilds Daniel O President and CEO Director | SCOLR Pharma Inc. (SCLR) | 13-Nov-06 | Market Purchase | 5,000 | $4.77 | $23,850.00 | 16% 32.0K to 37.0K | (95%) |
| 08-Nov-06 2:23 PM View: | Lucas Herbert L Jr Director | SCOLR Pharma Inc. (SCLR) | 07-Nov-06 | Option Exercise | 15,000 | $0.80 | $12,000.00 | 2% 657.4K to 672.4K | |
| 29-Aug-06 5:13 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 28-Aug-06 | Market Sale | 4,000 | $4.97 | $19,880.00 | (98%) 4.07K to 67 | 95% |
| 29-Aug-06 5:13 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 25-Aug-06 | Market Sale | 30,000 | $4.84 | $145,335.00 | (88%) 34.07K to 4.07K | 95% |
| 28-Aug-06 6:45 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 24-Aug-06 | Market Sale | 4,000 | $4.85 | $19,398.00 | (10%) 42.07K to 38.07K | 95% |
| 29-Aug-06 5:13 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 24-Aug-06 | Market Sale | 4,000 | $4.80 | $19,218.00 | (11%) 38.07K to 34.07K | 95% |
| 28-Aug-06 6:45 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 23-Aug-06 | Market Sale | 8,000 | $4.89 | $39,130.00 | (16%) 50.07K to 42.07K | 95% |
| 10-Aug-06 12:33 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 08-Aug-06 | Option Exercise | 50,000 | $1.05 | $52,500.00 | 100% 0 to 50.0K | |
| 28-Aug-06 6:45 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 05-Jul-06 | Market Sale | 3,900 | $4.81 | $18,742.00 | (98%) 3.97K to 67 | 95% |
| 28-Aug-06 6:45 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 30-Jun-06 | Market Sale | 21,800 | $4.71 | $102,777.00 | (85%) 25.77K to 3.97K | 95% |
| 28-Aug-06 6:44 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 29-Jun-06 | Market Sale | 22,900 | $4.78 | $109,448.00 | (47%) 48.67K to 25.77K | 95% |
| 28-Aug-06 6:44 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 28-Jun-06 | Market Sale | 18,000 | $4.84 | $87,131.00 | (27%) 66.67K to 48.67K | 95% |
| 13-Jun-06 4:24 PM View: | Wilds Daniel O Director | SCOLR Pharma Inc. (SCLR) | 13-Jun-06 | Market Purchase | 1,000 | $4.93 | $4,930.00 | 3% 31.0K to 32.0K | (95%) |
| 12-Jun-06 3:03 PM View: | Wilds Daniel O President and CEO Director | SCOLR Pharma Inc. (SCLR) | 12-Jun-06 | Market Purchase | 1,500 | $4.98 | $7,470.00 | 5% 29.5K to 31.0K | (95%) |
| 12-Jun-06 12:00 PM View: | Taglich Michael N Director | SCOLR Pharma Inc. (SCLR) | 08-Jun-06 | Market Purchase | 5,000 | $5.12 | $25,600.00 | 1% 388.29K to 393.29K | (95%) |
| 24-May-06 2:33 PM View: | Fassihi Reza Director | SCOLR Pharma Inc. (SCLR) | 23-May-06 | Option Exercise | 66,667 | $0.55 | $36,666.90 | 200% 33.33K to 100.0K |
